Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma

BACKGROUND: Response rates are primary endpoints in many oncology trials; however, correlation with overall survival (OS) is not uniform across cancer types, treatments, or lines of therapy. This study explored the association between objective response (OR) and OS in patients with chemotherapy-refr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Immunol Immunother
Main Authors: D’Angelo, Sandra P., Hunger, Matthias, Brohl, Andrew S., Nghiem, Paul, Bhatia, Shailender, Hamid, Omid, Mehnert, Janice M., Terheyden, Patrick, Shih, Kent C., Brownell, Isaac, Lebbé, Céleste, Lewis, Karl D., Linette, Gerald P., Milella, Michele, Schlichting, Michael, Hennessy, Meliessa H., Bharmal, Murtuza
Formato: Artigo
Idioma:Inglês
Publicado: Springer Berlin Heidelberg 2019
Assuntos:
Clinical Trial Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6447510/
https://ncbi.nlm.nih.gov/pubmed/30721341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-018-02295-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares